TickerGuard
Buy Day today: Neutral (48) Mixed market breadth · no major macro event
IRD

Opus Genetics, Inc.

Healthcare · Biotechnology

5.10$ +6.1% vs. previous close Closing price · As of: Sep 28, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement IRD
Line item 2019 2020 2021 2022 2023 2024 2025
– – – +6,665.7% -52.2% -42.3% +29.1%
– – -50.0% +0.0% +50.0% +66.7% +430.0%
– – – +6,665.7% -52.2% -42.3% +29.1%
– +180.2% +128.2% -5.4% +23.0% +52.1% +14.8%
– +54.8% +188.2% -10.5% +64.5% +52.3% +20.7%
– +376.2% +16.7% -7.2% +36.9% +146.7% -27.7%
– – – – -158.0% – –
– +385.9% -100.0% +350.0% +14,655.6% -100.0% –
– – – – -154.8% – –
– – – – -96.2% – –
– – – – -155.8% – –
– – – – -154.7% – –

Data as of: September 28, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?